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December 20101742 AbstractsConclusions: Due to the collateral artery network, CMI is a relatively
uncommon condition despite the prevalence of mesenteric atherosclerosis.
Open surgical revascularization is the most common treatment modality for
CMI. Our standard approach is a supra-celiac antegrade approach with a
bifurcated PTFE graft targeting the SMA and a branch of the celiac artery,
usually the hepatic artery. These distal sites were poor for anastomoses in this
case and instead we focused on the large meandering mesenteric artery as a
suitable target. The meandering mesenteric artery (of Moskowitz) connects
the middle colic artery to the left colic artery. Both the size and function as
a collateral between the SMA and IMAmake it a possible receiving vessel for
a bypass graft when the traditional vessels are unsuitable. The successful
resolution of the patient’s symptoms indicates that this bypass configuration
may be useful as an alternative solution to difficult cases of revascularization
for CMI.Carotid Endarterectomy for Treatment of Instent Restenosis
Alberto J. Gonzalez1, Michael A. Drummond2, R. Scott McCord2, H.
Edward Garrett Jr1, 1UT-Memphis, Memphis, Tenn; 2Vascular Associates
of Birmingham, Birmingham, Ala
Carotid stenting is now an established option in the treatment of
carotid stenosis. Recurrent stenosis following carotid stenting, however, can
be a management challenge. Repeat angioplasty may be ineffective or result
in recurrent instent stenosis. Obtaining distal control of the internal carotid
artery above the stented segment may be difficult. Instent restenosis was
encountered in three patients who underwent successful surgical endarter-
ectomy of the stented segment.
Case Reports: A 69-year-old gentleman who had undergone right
carotid stenting for a symptomatic 80% stenosis 2 years before presented
with symptoms of a right hemispheric TIA manifested by left limb paraple-
gia. Restenosis of the common carotid artery was identified by duplex
ultrasound and confirmed by arteriography. The common carotid was
thought to be too tortuous for repeat angioplasty. Operative therapy,
therefore, was undertaken. The stent was opened longitudinally with the
arteriotomy extending to the distal internal carotid in a standard fashion.
Endarterectomy of the plaque and stent was performed around a 12F shunt.
The artery was closed with a saphenous vein patch. The stent was well
incorporated within the plaque (Fig 1). No cranial nerve deficits were noted.
At 30 days the patient was stable with no evidence of carotid stenosis on
duplex ultrasound.
A 79-year-old gentleman who underwent left carotid stenting for symptom-
atic severe stenosis presented with recurrent left hemispheric symptoms 4
years later. Severe 90% instent restenosis was noted on duplex ultrasound
and confirmed by computed topographic angiography. Carotid endarterec-
tomy was performed around a 12F shunt with removal of the stent and
plaque. The artery was closed with a dacron patch. At 30 days, duplex
ultrasound revealed no evidence of restenosis.
An 86-year-old lady who had undergone right carotid stenting for a symp-
tomatic lesion returned 1 year later with severe symptomatic instent reste-
nosis. Duplex ultrasound confirmed a 75% stenosis at the distal end of the
stent. Repeat percutaneous therapy was avoided because of vessel tortuosity
and technical difficulties during the first procedure. An endarterectomy of
the plaque and stent with dacron patch angioplasty was performed without
complication. At 30 days, duplex ultrasound revealed no evidence of reste-
nosis.
Discussion: Considering the popularity of carotid stenting, an increas-
ing number of “high risk” patients are at risk for restenosis. These three
patients were all deemed “high risk” for surgical endarterectomy, yet subse-
quently underwent carotid endarterectomy without complication, calling
into question the current inclusion criteria for “high risk” patients. Although
carotid resection with interposition graft repair has been described for
treatment of recurrent instent stenosis, this is the first report of surgical
endarterectomy which includes the stented segment. The stents were easily
removed within the endarterectomy specimens using standard surgical tech-
nique. These cases demonstrate that carotid endarterectomy can be safely
performed for recurrent instent stenosis if the distal end of the stent can be
surgically controlled. Longer surveillance is necessary to determine the
patency of this procedure.
Bilateral Common Carotid Occlusion in Type IV Ehler Danlos Syn-
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Background: Ehlers-Danlos Syndrome (EDS) represents a group of
nine inheritable connective tissue disorders. Patients with type-IV or vascu-
lar EDS, autosomal dominant pattern of inheritance, may present with
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therapy for such disorders has been reserved for compelling indications in
which benefit clearly warrants risk, yet assessment of risk is largely clinical
with operative decisions guided by factors such as response to previous
operations and age at onset of index vascular complications. We report the
case of a patient with vascular EDS who required extra-anatomic carotid
revascularization.
Methods:A 52-year-oldmale presented withmultiple daily episodes of
dizziness and blurring of vision in the left eye. These symptoms had escalated
in frequency and severity over a period of 3 months. The patient had
documented vascular EDS. He had experienced a stroke in childhood and
had required enucleation of his right eye due to trauma. Carotid duplex
demonstrated bilateral common carotid artery occlusion with retrograde
blood flow in the left internal carotid artery and antegrade blood flow in the
right internal carotid artery. CTA confirmed findings of bilateral common
carotid artery occlusion (Fig) and internal carotid patency. After reviewing
the patient’s operative history including an uneventful nephrectomy per-
formed 2 years earlier, operative revascularization was recommended.
Results: We proceeded with cerebral revascularization with a left
subclavian to left internal carotid bypass using a 6 mm heparin-bonded
PTFE graft. Operation was accomplished and patient recovered unevent-
fully. He has enjoyed complete resolution of symptoms with unilateral
bypass, thus, the contralateral carotid occlusion has not required interven-
tion.
Conclusions:Vascular EDS is caused by a spontaneous point mutation
in the COL3A1 gene that encodes the chains of type III procollagen.
Increased tissue and particularly vessel fragility results in a higher risk of
intraoperative and late surgical complications; thus, elective surgery for
individuals with vascular EDS is generally discouraged. To our knowledge,
this is the first reported case of symptomatic bilateral common carotid
occlusion in a patient with vascular EDS. Our patient had compelling
symptoms that raised concern for imminent stroke, thus, prompting a
decision to operatively intervene. This case demonstrates that successful
outcomes may be achieved with operative management of vascular compli-
cations of EDS. However, long-term surveillance for anastomotic aneurysm
formation and development of lesions in other vascular beds is mandatory.
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Background: The purpose of this study is to identify proteins that are
differentially expressed in subjects with abdominal aortic aneurysm (AAA)
and matched controls. This information has the potential to increase under-
standing of the pathophysiology of AAA and to identify biomarkers suitable
to serve as a screening tool for AAA.
Methods: Blood was collected from patients with AAA (maximum
diameter greater than 4.5 cm) and matched controls (who had recent
imaging studies that excluded AAA). It was processed into plasma, and the
microparticles (MPs) were isolated by gel filtration chromatography fol-
lowed by ultrafiltration. The microparticle proteins were reduced, alkylated,
and digested with trypsin into peptides. The peptides were separated byliquid chromatography and analyzed by tandem mass spectrometry. The
spectra were searched using SEQUEST™ using a human international
protein index database and identified. Manual validation of at least one
MS/MS spectrum-peptide sequence match per protein was performed for
all proteins determined to be differentially expressed. T test and resampling-
based significance analysis for spectral counts methods were used to deter-
mined statistical significance.
Results: Peptides from 761 proteins were identified from the samples.
Spectral count analysis demonstrated that 149 proteins are differentially
expressed (P  .05). Proteins associated with hemolysis (13; 8.7%) were
excluded from further analysis because their presence was thought to be an
artifact of the blood collection process.Most of the remaining proteins (106;
71.6%) are over-expressed in AAA, but some (29; 19.6%) are under-ex-
pressed. Categories of proteins that are differentially expressed include cell
location (nuclear, mitochondrial, extracellular matrix, cytoskeleton, and
surface receptors), cell function (signaling proteins, ion pumps and channels,
angiogenesis, calcium handling, oxidative stress, small GTPases, inflamma-
tion, metabolic processes, transcription factors), cell types (mast cell and
platelet), and heat shock proteins.
Conclusions: Proteomic analysis of plasma MPs identified a large
number of proteins that are differentially expressed in patients with AAA
compared tomatched controls. PlasmaMPs from individuals with AAA have
a dramatically different MP proteome than matched controls. These differ-
ences may serve as a marker for AAA and may provide insight into the
pathophysiology of AAA.
Does Estrogen Replacement Improve Exaggerated Hyperplasia Fol-
lowing Endarterectomy?
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Background: We have observed that rats fed homocysteine-
supplemented diet exhibited increased vascular stenosis as a result of
neointimal hyperplasia following a carotid endarterectomy. Since neoin-
timal hyperplasia remains an important clinical limitation of both percu-
taneous and open vascular procedures, we sought to determine if estro-
gen replacement may prevent or attenuate neointimal hyperplasia in an
environment with hyperhomocysteinemia in rat carotid endarterectomy
model.
Methods: Forty young adult female Sprague-Dawley rats were divided
into six groups: (1) ovariectomized receiving 17-	 estradiol 20 
g/kg/day
on homocysteine diet (n  7), (2) ovariectomized receiving17-	 estradiol
20 
g/kg/day on rat chow diet (n  7), (3) ovariectomized receiving
placebo on homocysteine diet (n 5), (4) ovariectomized receiving placebo
on rat chow diet (n 5), (5) intact receiving placebo on homocysteine diet
(n  8), and intact receiving placebo on rat chow diet (n  8). Animals
on rat chow diet served as control group while those on homocysteine-
supplemented diet (4.5 g/kg of DL-homocysteine) served as exagger-
ated intimal hyperplasia response group. Prior to an open endarterec-
tomy, rats were implanted with an osmotic mini-pump to receive
estradiol or placebo and continued with their respective diets for 2 weeks
before and after carotid endarterectomy with vein patch closure. Carotid
arteries were harvested 2 weeks after the endarterectomy for histological
determinations. Endpoints included plasma homocysteine, serum estro-
gen, and intimal hyperplasia (% lumenal stenosis).
Results: Hyperhomocysteinemia did not produce any significant
changes in estradiol level in the rats on homocysteine diet vs those on control
diet. Plasma homocysteine level was significantly (P  .05) elevated in all
homocysteine supplemented groups vs controls except estradiol treated
group. Mean serum level of estradiol in intact animals was 20.31  2.12
pg/mL. Placebo-treated ovariectomized rats had mean serum estradiol level
of 13.04  1.31 pg/mLwhereas ovariectomized animals receiving estradiol
had a sevenfold higher level: 94.93  7.40 pg/mL. Intimal hyperplasia or
percent lumen stenosis was significantly increased in the placebo-treated
ovariectomized homocysteine group vs intact on homocysteine or control
diets (47.8%  1.74% vs 35.5%  1.57%, P  .0007 and vs 23.8  0.96%,
P  .0001, respectively). The exaggerated intimal hyperplasia in the place-
bo-treated ovariectomized homocysteine group was significantly reduced by
estrogen treatment and so was the plasma homocysteine level
(47.8  1.74% vs 29.6  0.69%, P .0001 and 19.76  1.67
mol/mL vs
4.65  0.66 
mol/mL, P  .0001, respectively). Estrogen replacement in
ovariectomized group on homocysteine diet reduced intimal hyperplasia to
that of the intact or ovariectomized rats on control diets (23.8%  0.96%,
P  .06 and 29.0%  5.51%, P  .87, respectively).
Conclusions: This preliminary study shows that estrogen has a bene-
ficial effect on the hyperplastic response. Estradiol was effective at lowering
plasma homocysteine levels. Treatment of ovariectomized rats with estradiol
resulted in reduction of intimal hyperplasia response following carotid
endarterectomy in rats on homocysteine or control diets as well as reducing
the homocysteine level.
